QRS 0.00% 7.0¢ qrsciences holdings limited

Ann: QRS Enters Into Term Sheet to Acquire API Bu, page-4

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 104 Posts.
    re: Ann: QRS Enters Into Term Sheet to Acquir... The company has entered into this purchase without yet having the money to pay for it, albeit it is non-binding at this point. Bank finance for a company with QRS track record would be prohibitively expensive. The only viable way to fund it will be via an equity issue... they mention a rights issue. As a long term shareholder, I pray they don't enter into arrangements with foreign non-bank finance providers as they did a few years back - those arrangements with Vision Opportunity and Platinum Partners were a disaster that cost shareholders a lot. It appeared QRS management didn't properly understand what they were doing. The terms of those convertible notes were always likely to produce a sad outcome for QRS shareholders. At least a rights issue is something the most basic management personnel can understand. Please keep it simple this time!
 
watchlist Created with Sketch. Add QRS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.